DocGo Inc. (DCGO) director awarded 150,000 RSUs vesting in 2026

Rhea-AI Filing Summary

DocGo Inc. director Ira Smedra reported a new equity award. On December 12, 2025, he received 150,000 restricted stock units ("RSUs") of DocGo common stock at a price of $0 per unit.

The RSUs were granted under DocGo’s 2021 Stock Incentive Plan and will vest on December 12, 2026, as long as the plan’s conditions are met. Each RSU represents the right to receive one share of DocGo common stock upon vesting. After this grant, Smedra beneficially owns 240,999 shares of DocGo common stock directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Smedra Ira

(Last) (First) (Middle)

C/O DOCGO INC.

685 THIRD AVENUE, 9TH FLOOR

(Street)

NEW YORK NY 10017

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DocGo Inc. [ DCGO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/12/2025		A		150,000(1)	A	$0	240,999	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2021 Stock Incentive Plan (the "Plan") that will vest on December 12, 2026, subject to the terms of the Plan. Each RSU represents the right to receive, upon vesting, one share of Common Stock, subject to the terms of the Plan.

Remarks:

	/s/ Jerilyn Laskie, as Attorney-in-Fact for Ira Smedra	12/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DocGo (DCGO) report for Ira Smedra?

DocGo reported that director Ira Smedra received a grant of 150,000 restricted stock units (RSUs) of DocGo common stock on December 12, 2025 at a price of $0 per unit.

When do Ira Smedra’s 150,000 DocGo (DCGO) RSUs vest?

The filing states that the 150,000 RSUs granted to Ira Smedra under DocGo’s 2021 Stock Incentive Plan will vest on December 12, 2026, subject to the terms of the plan.

What does each RSU granted to the DocGo (DCGO) director represent?

Each restricted stock unit (RSU) granted to the director represents the right to receive, upon vesting, one share of DocGo common stock, in line with the terms of the 2021 Stock Incentive Plan.

How many DocGo (DCGO) shares does Ira Smedra own after this RSU grant?

Following the reported RSU grant, Ira Smedra beneficially owns 240,999 shares of DocGo common stock, held with direct ownership status in the filing.

Was there any cash paid for the DocGo (DCGO) RSU grant to the director?

No cash was paid for the grant itself. The filing lists the transaction price for the 150,000 RSUs as $0, reflecting a typical equity incentive award structure rather than an open-market purchase.

Under which plan were the DocGo (DCGO) RSUs granted to the director?

The 150,000 RSUs granted to director Ira Smedra were issued under DocGo’s 2021 Stock Incentive Plan, which governs the terms and vesting conditions of this award.